How big is the Riboflavin Market?

The Riboflavin Market size is expected to reach USD 451.57 million in 2024 and grow at a CAGR of 6.65% to reach USD 623.06 million by 2029. Read More

What is the current Riboflavin Market size?

In 2024, the Riboflavin Market size is expected to reach USD 451.57 million. Read More

Who are the key players in Riboflavin Market?

BASF SE, Hubei Guangji Pharmaceutical Co. Ltd., Koninklijke DSM NV , Shanghai Acebright Pharmaceuticals Group Co. Ltd. and Xinfa Pharmaceutical Co. Ltd. are the major companies operating in the Riboflavin Market. Read More

Which is the fastest growing region in Riboflavin Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Riboflavin Market?

In 2024, the Asia-Pacific accounts for the largest market share in Riboflavin Market. Read More

What years does this Riboflavin Market cover, and what was the market size in 2023?

In 2023, the Riboflavin Market size was estimated at USD 423.41 million. The report covers the Riboflavin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Riboflavin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Riboflavin Companies

This report lists the top Riboflavin companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Riboflavin industry.